Training sites

Local education providers (LEPs) are organisations that have been approved by the GMC to deliver the pharmaceutical medicine specialty training programme. LEPs are responsible for supporting their trainees and specialty trainers and to fulfil the requirements in the GMC's 'Promoting excellence: standards for medical education and training'.

List of training sites for pharmaceutical medicine

The Pharmaceutical Medicine Deanery will keep the list up to date, but you are advised to verify that the training sites is still GMC-approved and suitable to support pharmaceutical physicians who want to undertake PMST. The list is for information only.

AbbVie Ltd
Aimmune Therapeutics UK Ltd
Alexion Pharma UK Ltd
Allergy Therapeutics Ltd
Alliance Pharmaceuticals Ltd
Almirall Ltd
Amgen Ltd
Astellas Pharma Europe Ltd
Astellas Pharma Ltd
AstraZeneca UK Ltd

LEP approval

Pharmaceutical organisations that want to deliver the PMST curriculum, must be approved by the GMC . A Deanery Specialty Advisor (SA) will assess the pharmaceutical organisations suitability to be approved as a training location. If the SA is satisfied that the organisation can deliver the PMST curriculum, the organisation will need to complete and return the LEP agreement. When the LEP agreement has been fully signed, the Pharmaceutical Medicine Deanery will submit a training site approval application to the GMC. After the GMC has approved the organisation as a training location, its name will be added to the GMC’s list of approved training locations.